Abstract:Fearnley et al reported an ataxia case with a 46 of 29 CAG repeats in THAP11, comorbid with a 22-CAG repeat expansion in CACNA1A from European-ancestry ataxia cohort. This patient was diagnosed as hereditary ataxia at the age of 40 and Parkinson's disease at 53. The comorbidity of two polyglutamine (polyQ) diseases may complicate the phenotype and further assessment is warranted. Nevertheless, this is the first time that CAG expansion greater than 45 repeats in THAP11 was found beyond Chinese ataxia population. Therefore, this patient further confirmed this new subtype of spinocerebellar ataxia (SCA). In addition, Fearnley et al also investigated the normal expansion ranging from 19 to 39 repeats in THAP11 from 2504 individuals in 1000 Genomes. In general, these findings suggest that ATX-THAP11 is not limited to Asian. As the latest SCA included in Online Mendelian Inheritance in Man (OMIM) is SCA50, the new SCA subtype caused by the CAG expansion in THAP11 identified by us is appropriately named ATX-THAP11/SCA51. The pathogenic mechanism of polyQ diseases is widely attributed to the toxicity of abnormal proteins containing stretches of polyQ residues.1 We observed an increase in the length of glutamine correlates with a more severe phenotype in our ATX-THAP11/SCA51 family.2 Interestingly, expansion of CAG repeats interrupted by CAA is common in polyQ disease, which encodes the same glutamine for polyQ stretch, but may lead to distinct RNA secondary structures.1 In recent years, several reports have explored the impact of various DNA structures within CAG repeats on the severity of polyQ diseases. Three independent studies have reported that in individuals with Huntington's disease (HD), a reduction in CAA insertions and an increase in uninterrupted CAG repeats are associated with an earlier onset age of HD.3, 4 Conversely, increased CAA insertions are linked to delayed disease onset.3 Further comparisons among different HD mouse models have demonstrated that longer uninterrupted CAG repeats are associated with striatum-selective transcriptionopathy, possibly because of CAG repeat instability and nuclear aggregation.5 Another intriguing observation is that pure CAG repeats in ATXN2 are associated with SCA2, whereas CAG repeats in ATXN2 causing amyotrophic lateral sclerosis (ALS) and Parkinson's disease are predominantly interrupted by CAA.6 In Drosophila models, ataxin-2 encoded by pure CAG repeats induces retinal and neurotoxicity, whereas CAA insertions or only CAA repeats do not induce toxicity, despite producing the same protein.7 In our large family affected by ATX-THAP11/SCA51, we noted a decrease in CAA insertions and an increase in pure CAG length. However, there was no decrease in CAA insertions in our other family or in the patient reported by Fearnley et al. Currently, because of the limited number of ATX-THAP11/SCA51 patients, whether CAA interruption modulates pathogenesis of polyQ aggregation and influences clinical phenotypes needs further exploration. In the future, it is necessary to detect CAG repeat expansion of THAP11 across ethnically and geographically different ataxia populations to clarify its genotype–phenotype characteristics and pathogenesis of ATX-THAP11/SCA51. The author declares that the research was conducted in the absence of other commercial or financial relationships that could be construed as a potential conflict of interest. (1) Research project: A. Conception, B. Organization, C. Execution; (2) Statistical Analysis: A. Design, B. Execution, C. Review and Critique; (3) Manuscript: A. Writing of the First Draft, B. Review and Critique. H.X., H.J., and N.Z. contributed to the conception and design of the study, as well as reviewed the draft; D.T., W.J., and Z.C. contributed to the analysis of data and drafting of the text. Not applicable.

Evolutionary model of repeat insertions in Ataxin‐3 traces the origin of the polyglutamine stretch to an ancestral ubiquitin binding module

Research on Screening and Identification of Proteins Interacting with Ataxin-3.

Inheritance Patterns of ATCCT Repeat Interruptions in Spinocerebellar Ataxia Type 10 (SCA10) Expansions.

Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation

The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases

Identifying Novel Interruption Motifs in Spinocerebellar Ataxia Type 10 Expansions

SMRT Sequencing of Long Tandem Nucleotide Repeats in SCA10 Reveals Unique Insight of Repeat Expansion Structure.

ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3

Phosphorylation of ataxin-3 by glycogen synthase kinase 3beta at serine 256 regulates the aggregation of ataxin-3

A GGC-repeat expansion in ZFHX3 encoding polyglycine causes spinocerebellar ataxia type 4 and impairs autophagy

The BAG2 and BAG5 Proteins Inhibit the Ubiquitination of Pathogenic Ataxin3-80Q.

Age-dependent somatic expansion of the ATXN3 CAG repeat in the blood and buccal swab DNA of individuals with spinocerebellar ataxia type 3/Machado-Joseph disease

Toward understanding Machado–Joseph disease

ATX-3, CDC-48 and UBXN-5: a new trimolecular complex in Caenorhabditis elegans

Targeting the VCP-binding motif of ataxin-3 improves phenotypes in Drosophila models of Spinocerebellar Ataxia Type 3

Structural and dynamic studies reveal that the Ala-rich region of ataxin-7 initiates α-helix formation of the polyQ tract but suppresses its aggregation

The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease

Reply To: "THAP11 CAG Expansion Beyond Chinese-Ancestry Cohorts: an Examination of 1000 Genomes and UK Biobank"

Polyglutamine Expansion Alters the Dynamics and Molecular Architecture of Aggregates in Dentatorubropallidoluysian Atrophy

Advancing molecular, phenotypic and mechanistic insights of pathogenic expansions (SCA27B)

Degron capability of the hydrophobic C‐terminus of the polyglutamine disease protein, ataxin‐3